Panel Discussion: Improving Clinical Endpoints & Optimizing Trial Design
Time: 2:00 pm
day: Conference Day Two
Details:
- Moving from oncology to autoimmunity, do we need to adapt clinical trial design? Are basket trials the way forward?
- How do we improve communication between hematology, rheumatology, and oncology disciplines?
- What should clinical readouts and endpoints look like for autoimmune disease? How can we implement surrogate endpoints?
